tyrosine has been researched along with lovastatin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hidaka, Y; Ishida, F; Kamei, T; Nagata, Y | 1 |
| Jeng, I; Klemm, N; Proctor, B | 1 |
| Corey, SJ; McGuire, TF; Romero, GG; Sebti, SM; Xu, XQ | 1 |
| Corey, SJ; McGuire, TF; Sebti, SM | 1 |
| Bolen, JB; Eiseman, E; Penhallow, RC; Shakarjian, MP | 1 |
| Blaskovich, MA; McGuire, TF; Romero, G; Sebti, SM; Xu, XQ | 1 |
| Fisher, SK; Linseman, DA; McEwen, EL; Sorensen, SD | 1 |
| Kiehl, MG; Koch, OM; Müller, C; van de Loo, J | 1 |
| Maddala, RL; Rao, PV; Reddy, VN | 1 |
| Banger, N; Berdel, WE; Chou, TC; Kiehl, M; Koch, OM; Müller-Tidow, C; Probst, M; Serve, H; Sindermann, JR; Zühlsdorf, M | 1 |
| Bragado, MJ; Cerezo-Guisado, MI; Garcia-Marin, LJ; Lorenzo, MJ | 1 |
| Cirone, M; D'Orazi, G; Gilardini Montani, MS; Gonnella, R; Pompili, C; Romeo, MA; Santarelli, R | 1 |
12 other study(ies) available for tyrosine and lovastatin
| Article | Year |
|---|---|
Effects of simvastatin (MK-733) on branched pathway of mevalonate.
Topics: Animals; Anticholesteremic Agents; Cell Line; Cholesterol; DNA; Dolichols; Humans; Liver Neoplasms, Experimental; Lovastatin; Mevalonic Acid; Proteins; Simvastatin; Thymidine; Tumor Cells, Cultured; Tyrosine; Ubiquinone | 1990 |
Insensitivity of ubiquinone biosynthesis in glioblastoma cells to an epileptogenic drug, U18666A.
Topics: Androstenes; Animals; Anticholesteremic Agents; Cell Line; Glioma; Hydroxybenzoates; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Methionine; Mevalonic Acid; Naphthalenes; Parabens; Rats; Tyrosine; Ubiquinone | 1984 |
Lovastatin disrupts early events in insulin signaling: a potential mechanism of lovastatin's anti-mitogenic activity.
Topics: Animals; Cell Line; Fibroblasts; Humans; Insulin; Insulin Receptor Substrate Proteins; Kinetics; Lovastatin; Macromolecular Substances; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphotransferases (Alcohol Group Acceptor); Phosphotyrosine; Rats; Receptor, Insulin; Signal Transduction; Transfection; Tyrosine | 1994 |
Lovastatin inhibits platelet-derived growth factor (PDGF) stimulation of phosphatidylinositol 3-kinase activity as well as association of p85 subunit to tyrosine-phosphorylated PDGF receptor.
Topics: 3T3 Cells; Adenosine Triphosphate; Animals; Fibroblasts; Insulin; Kinetics; Lovastatin; Macromolecular Substances; Mice; Phosphatidylinositol 3-Kinases; Phosphotransferases (Alcohol Group Acceptor); Phosphotyrosine; Platelet-Derived Growth Factor; Protein Binding; Receptors, Platelet-Derived Growth Factor; Tyrosine | 1993 |
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibition in a rat mast cell line. Impairment of tyrosine kinase-dependent signal transduction and the subsequent degranulation response.
Topics: Animals; Benzoquinones; Cell Degranulation; Cell Line; Econazole; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin E; Lactams, Macrocyclic; Lovastatin; Mast Cells; Phosphorylation; Protein-Tyrosine Kinases; Quinones; Rats; Receptors, Fc; Signal Transduction; Tyrosine | 1993 |
Lovastatin inhibits the stimulation of mitogen-activated protein kinase by insulin in HIRcB fibroblasts.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Enzyme Activation; Fibroblasts; Humans; Insulin; Lovastatin; Mevalonic Acid; Mitogen-Activated Protein Kinase 1; Phosphorylation; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; ras Proteins; Rats; Receptor, Insulin; Tyrosine | 1996 |
Cytoskeletal and phosphoinositide requirements for muscarinic receptor signaling to focal adhesion kinase and paxillin.
Topics: Actins; Androstadienes; Cell Adhesion; Cell Adhesion Molecules; Chromones; Cytochalasin D; Cytoskeletal Proteins; Cytoskeleton; Enzyme Inhibitors; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; GTP-Binding Proteins; Humans; Lovastatin; Morpholines; Muscarinic Agonists; Neuroblastoma; Nucleic Acid Synthesis Inhibitors; Paxillin; Phosphatidylinositol Phosphates; Phosphatidylinositols; Phosphoproteins; Phosphorus Radioisotopes; Phosphorylation; Protein-Tyrosine Kinases; Receptor, Insulin; Receptors, Muscarinic; Second Messenger Systems; Tumor Cells, Cultured; Tyrosine; Wortmannin | 1998 |
Lovastatin induces p21WAF1/Cip1 in human vascular smooth muscle cells: influence on protein phosphorylation, cell cycle, induction of apoptosis, and growth inhibition.
Topics: Apoptosis; Cell Cycle; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dose-Response Relationship, Drug; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Muscle, Smooth, Vascular; Phosphorylation; Tyrosine | 1999 |
Lovastatin-induced cytoskeletal reorganization in lens epithelial cells: role of Rho GTPases.
Topics: Actins; Animals; beta Catenin; Blotting, Western; Cadherins; Cell Adhesion; Cell Size; Cells, Cultured; Cytoskeletal Proteins; Cytoskeleton; Epithelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lens, Crystalline; Lovastatin; Paxillin; Phosphoproteins; Phosphorylation; Protein Prenylation; rac GTP-Binding Proteins; rho GTP-Binding Proteins; Swine; Trans-Activators; Tyrosine; Vinculin | 2001 |
Synergistic growth inhibitory effects of interferon-alpha and lovastatin on bcr-abl positive leukemic cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; DNA Fragmentation; Dose-Response Relationship, Drug; Flow Cytometry; Fusion Proteins, bcr-abl; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon alpha-2; Interferon-alpha; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lovastatin; Mevalonic Acid; Phosphorylation; Protein Prenylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins p21(ras); Recombinant Proteins; Serine; Threonine; Time Factors; Tyrosine | 2003 |
Lovastatin inhibits the growth and survival pathway of phosphoinositide 3-kinase/protein kinase B in immortalized rat brain neuroblasts.
Topics: Androstadienes; Animals; Apoptosis; Cell Division; Cell Line, Transformed; Cell Survival; Chromones; Enzyme Inhibitors; Eukaryotic Initiation Factor-4E; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Morpholines; Nerve Tissue Proteins; Neurons; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Ribosomal Protein S6 Kinases, 70-kDa; Stem Cells; Tyrosine; Wortmannin | 2005 |
Lovastatin reduces PEL cell survival by phosphorylating ERK1/2 that blocks the autophagic flux and engages a cross-talk with p53 to activate p21.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Humans; Lovastatin; Lymphoma, Primary Effusion; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Niacinamide; Phenylurea Compounds; Phosphorylation; STAT3 Transcription Factor; Tumor Suppressor Protein p53; Tyrosine | 2021 |